GENE ONLINE|News &
Opinion
Blog

Interviews
How Can Taiwan’s Biopharma Seize the Next Global Business Opportunity? – An Interview with Dr. Jerome Shen
2021-10-17
Revealing the Underestimated Potential of Natural RNA Editing – An Interview with Dr. Trees-Juen Chuang
2021-09-17
Current Challenges and Future Opportunities of Artificial RNA Editing – An Interview with Professor Toshifumi Tsukahara
2021-08-26
Years After Playing Second Fiddle to CRISPR, RNA Editing Comes Into Its Own – An Interview with Dr. Joshua Rosenthal
2021-08-25
The Maturation of Blood-Based Diagnostics to Nip Cancers in the Bud: An Interview with Dr. Jimmy Lin
2021-06-02
The Transformative Potential of Gene Therapies for Hemophilia
2021-04-08
How the ICT Industry is Poised to Transform Healthcare? – An Interview with AUO President Frank Ko
2020-11-26
Prof. Han van den Bosch: The Mammoth Task of Vaccinating the World
2020-11-02
HoldingTOP Delivers a Mobilized Long-Term Care Service, a First in Taiwan
2020-10-13Partner
Building a Biomedical Value Chain and Accelerating the Development of the Biomedical Industry
2020-07-29Partner
The Profound Impact of Duplex Sequencing: An Interview with Jesse Salk, CEO, TwinStrand Biosciences
2020-07-20
Dr. Joseph Kvedar: The Potential of Telemedicine in the Era of Digitalization
2020-05-07
Peeking into the Future of Synthetic Biology and Gene Editing, an Exclusive Interview with Dr. George Church
2020-02-13
The Rejuvenated Promise of RNA Therapeutics
2020-01-07
Envisioning a Future of Superior, Cost-Effective Healthcare: An interview with Dr. Jeong-Sun Seo
2019-12-23
1 2 3
LATEST
10x Genomics Eyes Regional Opportunities in Asia-Pacific, Launches First Overseas Manufacturing Hub
2021-10-26
Shaping the Future of the Beauty Industry: Can Skin Microbiome Products Succeed Cosmetics?
2021-10-25
Sanofi, Regeneron’s Dupixent Shines in Phase 3 Trial for Prurigo Nodularis
2021-10-25
ReCode Therapeutics Raises $80 Million in Series B to Advance Gene Therapy & LNP Delivery Platform
2021-10-23
Intellia’s CRISPR Drug Claims FDA Orphan Drug Designation to Treat ATTR Amyloidosis
2021-10-22
Sio Gene Therapies Touts Positive Safety and Biomarker Data for GM1 Gangliosidosis Candidate
2021-10-22
Daiichi Sankyo to Launch mRNA Covid-19 Vaccine in 2022, Shionogi Presents Clinical Results of Covid-19 Oral Drug
2021-10-22
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!